KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
Kunihiko Hinohara(Broad Institute), Kornélia Polyák(Dana-Farber Cancer Institute), Alexander Meissner(Max Planck Institute for Molecular Genetics), Myles Brown(Harvard University), Sébastien Vigneau(Broad Institute), Stephen C. Kales(National Institutes of Health), Guillermo Peluffo(Harvard University), Alexander A. Gimelbrant(Harvard University), Anne Fassl(Harvard University), Thomas O. McDonald(Harvard University), Rinath Jeselsohn(Dana-Farber Cancer Institute), Thomas Madsen(Deakin University), Ganesha Rai(National Institutes of Health), Jacob D. Jaffe(Broad Institute), Shawn B. Egri(Broad Institute), Anton Simeonov(National Institutes of Health), Ajit Jadhav(National Institutes of Health), Kyomi J. Igarashi(California Institute for Regenerative Medicine), Nikhil Wagle(Dana-Farber Cancer Institute), David J. Maloney(National Institutes of Health), Piotr Siciński(Harvard University), Ofir Cohen(Broad Institute), Franziska Michor(Dana-Farber Cancer Institute), Lina Ding, Hua‐Jun Wu(Harvard University), Malvina Papanastasiou(Broad Institute), Kimiyo N. Yamamoto(Harvard University), Madhu Lal‐Nag(National Center for Advancing Translational Sciences)
Cited by 42
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k